MetaStat Inc (MTST)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:MetaStat Inc (MTST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013337
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MetaStat Inc (MetaStat) is a biotechnology company that discovers and develops personalized diagnostic and therapeutic treatment solutions for cancer patients. The company develops therapeutic product candidates based on novel approach that offers intracellular Mena protein isoforms drugable targets. It offers products such as MetaSite Breast, an immunohistochemistry-based assay developed to predict the spread of cancer through the bloodstream to other organs; and MenaCalc Lung, a test evaluated to predict the likelihood of metastasis in adenocarcinoma of the lung. MetaStat also provides MenaCalc Prostate, a diagnostic for prostate cancer; and MenaBloc, a platform technology that develops therapies that can preemptively reduce or eliminate metastasis. Its technologies are based on identification of a pathway for developing metastatic disease in solid epithelial-based tumors. The company develops its products using mena protein, a potentiator and modulator of cellular migration. MetaStat is headquartered in Boston, Massachusetts, the US.

MetaStat Inc (MTST) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
MetaStat Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
MetaStat Inc, Medical Devices Deals, 2011 to YTD 2017 9
MetaStat Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
MetaStat Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
MetaStat Enters Into Licensing Agreement With Albert Einstein College of Medicine For Metastatic Cell Technology Patents 11
Licensing Agreements 12
ASET Therapeutics Enters into Licensing Agreement with MetaStat 12
MetaStat Enters Into Licensing Agreements For Alternative Splicing Program 14
Equity Offering 16
MetaStat Raises USD0.4 Million in Second Tranche of Private Placement of Shares and Preferred Shares 16
MetaStat Raises USD2.1 Million in First Tranche of Private Placement of Shares and Preferred Shares 17
MetaStat Raises USD2.1 Million in Final Tranche of Private Placement of Series B Preferred Shares 18
MetaStat Completes Private Placement Of Shares For US$0.81 Million 20
Acquisition 21
PhotoVoltaic Solar Cells Acquires MetaStat, Life Science Company 21
MetaStat Inc – Key Competitors 22
MetaStat Inc – Key Employees 23
MetaStat Inc – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Corporate Communications 25
Aug 03, 2017: MetaStat Welcomes Renato T. Skerlj, Ph.D., Accomplished Drug Developer to Its Scientific and Clinical Advisory Board 25
May 08, 2017: MetaStat Elevates Jerome B. Zeldis, M.D., Ph.D. to Chairman of the Board and Appoints Douglas A. Hamilton, MetaStat’s President and CEO to its Board of Directors 26
Apr 27, 2016: MetaStat Appoints Jerome B. Zeldis, M.D., Ph.D. to its Board of Directors 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
MetaStat Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
MetaStat Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
MetaStat Inc, Deals By Therapy Area, 2011 to YTD 2017 8
MetaStat Inc, Medical Devices Deals, 2011 to YTD 2017 9
MetaStat Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
MetaStat Enters Into Licensing Agreement With Albert Einstein College of Medicine For Metastatic Cell Technology Patents 11
ASET Therapeutics Enters into Licensing Agreement with MetaStat 12
MetaStat Enters Into Licensing Agreements For Alternative Splicing Program 14
MetaStat Raises USD0.4 Million in Second Tranche of Private Placement of Shares and Preferred Shares 16
MetaStat Raises USD2.1 Million in First Tranche of Private Placement of Shares and Preferred Shares 17
MetaStat Raises USD2.1 Million in Final Tranche of Private Placement of Series B Preferred Shares 18
MetaStat Completes Private Placement Of Shares For US$0.81 Million 20
PhotoVoltaic Solar Cells Acquires MetaStat, Life Science Company 21
MetaStat Inc, Key Competitors 22
MetaStat Inc, Key Employees 23

★海外企業調査レポート[MetaStat Inc (MTST)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aarti Drugs Ltd (AARTIDRUGS):企業の財務・戦略的SWOT分析
    Summary Aarti Drugs Ltd (ADL), is a contract manufacturer of pharmaceutical products that offers therapeutic products, ingredients, bulk drugs, and chemicals. The company's products include active pharmaceutical ingredients, pharma intermediates, and specialty chemicals. Its active pharmaceutical in …
  • Noble Energy Inc (NBL):石油・ガス:M&Aディール及び事業提携情報
    Summary Noble Energy Inc (Noble) is an independent energy company that explores for and produces crude oil, natural gas and natural gas liquids (NGLs). The company’s portfolio includes both US unconventional and global offshore conventional assets. Noble has operations in the Denver-Julesburg (DJ) B …
  • Icagen Inc:企業の戦略的SWOT分析
    Icagen Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Penn Virginia Oil & Gas Corporation Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Penn Virginia Oil & Gas Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Penn Virginia Oil & Gas Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that …
  • Leaf Group Ltd:企業のM&A・事業提携・投資動向
    Leaf Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Leaf Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Cardiovascular Systems Inc (CSII):製品パイプライン分析
    Summary Cardiovascular Systems Inc (CSI) is a medical device company that develops and commercializes products for treating peripheral and coronary vascular disease. The company offers products such as peripheral orbital atherectomy system, coronary orbital atherectomy system, crowns, and accessorie …
  • Qualicaps Inc:企業の戦略的SWOT分析
    Qualicaps Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Tetra Technologies, Inc.:企業の戦略・SWOT・財務情報
    Tetra Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tetra Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Chr. Hansen Holding A/S
    Chr. Hansen Holding A/S - Strategy, SWOT and Corporate Finance Report Summary Chr. Hansen Holding A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Viridian Group Investments Ltd:企業の戦略的SWOT分析
    Viridian Group Investments Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • MEDITE Cancer Diagnostics Inc (MDIT):医療機器:M&Aディール及び事業提携情報
    Summary MEDITE Cancer Diagnostics Inc (MEDITE), formerly CytoCore, Inc., specializes in the development, engineering, manufacturing and marketing of premium medical devices and consumables for detection, risk assessment and diagnosis of cancer and related diseases. Its major devices include ultrason …
  • Lowe’s Companies, Inc.:戦略・SWOT・企業財務分析
    Lowe's Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Lowe's Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Alliance Oil Co Ltd:企業の戦略的SWOT分析
    Alliance Oil Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • ADInstruments Pty Ltd:企業の戦略的SWOT分析
    ADInstruments Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • GridEdge Networks Inc:企業の戦略的SWOT分析
    GridEdge Networks Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • VTB Bank:企業の戦略・SWOT・財務情報
    VTB Bank - Strategy, SWOT and Corporate Finance Report Summary VTB Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Vaxart Inc (VXRT):製薬・医療:M&Aディール及び事業提携情報
    Summary Vaxart Inc (Vaxart) is a clinical stage biotechnology company which develops oral recombinant protein vaccines based on its proprietary oral vaccine delivery platform to treat infections. The company develops tablet vaccines for seasonal and pandemic influenza, norovirus, and respiratory syn …
  • Bartlett Holdings Inc:電力:M&Aディール及び事業提携情報
    Summary Bartlett Holdings Inc, doing business as BHI Energy, a subsidiary of AE Industrial Partners LLC, is a specialty service and staffing solutions provider. The company offers complete maintenance, radiological and professional technical staffing solutions. It provides power services including m …
  • Chorus Clean Energy AG (CU1):電力:M&Aディール及び事業提携情報
    Summary Chorus Clean Energy AG (Chorus Clean) is a renewable energy company that offers solar energy and wind energy development services. The company's services include technical and commercial management, asset sourcing, operational management, due diligence, documentation and reporting, commercia …
  • BSH Hausgerate GmbH:企業の戦略・SWOT・財務情報
    BSH Hausgerate GmbH - Strategy, SWOT and Corporate Finance Report Summary BSH Hausgerate GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆